Skip to main content
. 2017 Jul 6;8(51):89203–89213. doi: 10.18632/oncotarget.19038

Table 1. Clinicopathological characteristics of patients with early and late locoregional recurrence at time of primary tumor detection.

ELR(<12m)
(N=30)
LLR(≥12m)
(N=44)
P
Age
 <65 28(40.6%) 41(59.4%)
 ≥65 2(40.0%) 3(60.0%) 0.980
Gender
 Male 20(38.5%) 32(61.5%)
 Female 10(45.5%) 12(54.5%) 0.575
T stage
 T1-T2 4(33.3%) 8(66.7%)
 T3-T4 26(41.9%) 36(58.1%) 0.579
N stage
 N0-N1 7(41.2%) 10(58.8%)
 N2-N3 23(40.4%) 34(59.6%) 0.951
Vascular invasion
 NO 19(35.2%) 35(64.8%)
 YES 11(55.0%) 9(45.0%) 0.123
Pathological type
 SRC 5(33.3%) 10(66.7%)
 PDA 20(45.5%) 24(54.5%)
 MDA 4 (44.4%) 5(55.6%)
 HDA 1 (16.7%) 5(83.3%) 0.524

SRC: signet-Ring Cell carcinoma

PDA: poor-differentiated adenocarcinom

MDA: middler-differentiated adenocarcinom

HAD: high-differentiated adenocarcinom